Nilutamide clinical trials
Also written Nilandron.
How each study uses nilutamide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 19 Sept 1996 · NILANDRON · NDA 020169 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 1996 (1)
| Year | Studies |
|---|---|
| 1996 | 1 |
| 1999 | 1 |
| 2000 | 1 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 4
NCIC Clinical Trials Group (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Duke University (1)
Often tested with
Tested in the same studies.
Bicalutamide (2) · Flutamide (2) · Buserelin (1) · Cyproterone Acetate (1) · Cyproterone (1) · Goserelin (1) · Leuprolide (1) · Doxorubicin (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antiandrogens source
Studies
Open first, then newest update. How each study uses nilutamide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate CancerCompletedPhase 3NCIC Clinical Trials GroupNCT00003653Written as nilutamide
- Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate CancerCompletedPhase 3M.D. Anderson Cancer CenterNCT00002855Written as Nilutamide
- Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate CancerCompletedPhase 2National Cancer Institute (NCI)NCT00020254Written as nilutamide
- Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate CancerTerminatedPhase 2Duke UniversityNCT00918385Written as Nilutamide
Given beside what is tested · 6 — nilutamide is usual care or a partner of the new treatment
- Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerRecruitingPhase 3SWOG Cancer Research NetworkNCT03678025Written as Nilutamide
- Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by SurgeryActive, not recruitingPhase 2/3NRG OncologyNCT03070886Written as Nilutamide
- Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate CancerActive, not recruitingPhase 2M.D. Anderson Cancer CenterNCT01786265Written as Nilutamide
- Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate CancerCompletedPhase 3NCIC Clinical Trials GroupNCT00002633Written as nilutamide
- S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate CancerCompletedPhase 2SWOG Cancer Research NetworkNCT00028769Written as nilutamide
- Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate CancerTerminatedPhase 1National Cancer Institute (NCI)NCT00512668Written as nilutamide
Codes
What other systems call nilutamide · ClinicalTrials.gg INT002743
- MeSH (NLM) C021277nilutamideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 51G6I8B902NILUTAMIDEConfirmed FDA, NLM, Wikidata
- RxNorm 31805Confirmed FDA, Wikidata
- Wikidata Q3877030nilutamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1173NilutamideOne source FDA
- DrugBank DB00665One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C021277 | nilutamide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 51G6I8B902 | NILUTAMIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 31805 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3877030 | nilutamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1173 | Nilutamide | One source FDA |
| DrugBank | DB00665 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.